Works by Yang, Wenying


Results: 141
    1
    2
    3
    4
    5
    6
    7

    Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial

    Published in:
    Journal of Diabetes Investigation, 2016, v. 7, n. 1, p. 85, doi. 10.1111/jdi.12364
    By:
    • Yang, Wenying;
    • Zhu, Lvyun;
    • Meng, Bangzhu;
    • Liu, Yu;
    • Wang, Wenhui;
    • Ye, Shandong;
    • Sun, Li;
    • Miao, Heng;
    • Guo, Lian;
    • Wang, Zhanjian;
    • Lv, Xiaofeng;
    • Li, Quanmin;
    • Ji, Qiuhe;
    • Zhao, Weigang;
    • Yang, Gangyi
    Publication type:
    Article
    8
    9

    Epidemic trend of diabetes in China.

    Published in:
    Journal of Diabetes Investigation, 2014, v. 5, n. 5, p. 478, doi. 10.1111/jdi.12254
    By:
    • Chen, Xiaoping;
    • Yang, Wenying
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial.

    Published in:
    2022
    By:
    • Yao, Jun;
    • Guo, Xiaohui;
    • Sun, Li;
    • Han, Ping;
    • Lv, Xiaofeng;
    • Zhang, Xiuzhen;
    • Mo, Zhaohui;
    • Yang, Wenying;
    • Zhang, Lihui;
    • Wang, Zhanjian;
    • Zhu, Lvyun;
    • Li, Quanmin;
    • Yang, Tao;
    • Wang, Wenbo;
    • Xue, Yaoming;
    • Shi, Yongquan;
    • Lu, Juming;
    • Peng, Yongde;
    • Zhang, Fan;
    • Yan, Dewen
    Publication type:
    journal article
    49
    50